Technical Analysis for OPNT - Opiant Pharmaceuticals, Inc.
| ADX | Long-Term | Intermediate-Term | Short-Term |
|---|---|---|---|
| Weak or Absent | Down | Flat | Up |
| See historical OPNT trend table... | |||
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Jan 18 | Crossed Above 50 DMA | Bullish | 0.00% |
| Jan 18 | BB Squeeze Ended | Range Expansion | 0.00% |
| Jan 18 | Up 3 Days in a Row | Strength | 0.00% |
| Jan 18 | Up 4 Days in a Row | Strength | 0.00% |
| Jan 18 | Upper Bollinger Band Touch | Strength | 0.00% |
| Jan 17 | 50 DMA Resistance | Bearish | 0.83% |
| Jan 17 | Shooting Star Candlestick | Bearish | 0.83% |
| Jan 17 | Non-ADX 1,2,3,4 Bearish | Bearish Swing Setup | 0.83% |
| Jan 17 | Pocket Pivot | Bullish Swing Setup | 0.83% |
| Jan 17 | Bollinger Band Squeeze | Range Contraction | 0.83% |
Free Daily (Stock) Chart Reading
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 2018-11-07
- Sector: Healthcare
- Industry: Biopharmaceuticals
Opiant Pharmaceuticals, Inc., formerly Lightlake Therapeutics, Inc., is a specialty pharmaceutical company. The Company develops pharmacological treatments for substance use, addictive and eating disorders. The Company has developed NARCAN (naloxone hydrochloride) Nasal Spray, a treatment to reverse opioid overdoses, which was conceived, licensed, developed and approved by the United States Food and Drug Administration (FDA). The Company's pipeline of product candidates includes a treatment for Binge Eating Disorder (BED), a treatment for Bulimia Nervosa (BN), a treatment for Cocaine Use Disorder (CocUD) and a heroin vaccine. The Company also is focused on other treatment opportunities.
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength | |||
| Summary: | Counts: 0 bullish, 2 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies. | ||
See more OPNT news...
Indicators
| Indicator | Value |
|---|---|
| 52 Week High | 32.28 |
| 52 Week Low | 12.02 |
| Average Volume | 23,956 |
| 200-Day Moving Average | 16.8577 |
| 50-Day Moving Average | 15.1036 |
| 20-Day Moving Average | 14.137 |
| 10-Day Moving Average | 14.2885 |
| Average True Range | 1.0167 |
| ADX | 23.56 |
| +DI | 25.6339 |
| -DI | 17.2478 |
| Chandelier Exit (Long, 3 ATRs ) | 13.1999 |
| Chandelier Exit (Short, 3 ATRs ) | 15.0701 |
| Upper Bollinger Band | 15.1908 |
| Lower Bollinger Band | 13.0832 |
| Percent B (%b) | 0.98 |
| BandWidth | 14.908396 |
| MACD Line | -0.1319 |
| MACD Signal Line | -0.3417 |
| MACD Histogram | 0.2098 |
| Fundamentals | Value |
|---|---|
| Market Cap | 30.85 Million |
| Num Shares | 2.04 Million |
| EPS | 2.94 |
| Price-to-Earnings (P/E) Ratio | 5.15 |
| Price-to-Sales | 4.44 |
| Price-to-Book | 18.77 |
| PEG Ratio | 0.00 |
| Dividend | 0.00 |
| Dividend Yield | 0.00% |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 16.33 | ||||
| Resistance 3 (R3) | 16.22 | 15.71 | 16.13 | ||
| Resistance 2 (R2) | 15.71 | 15.41 | 15.77 | 16.07 | |
| Resistance 1 (R1) | 15.43 | 15.22 | 15.57 | 15.54 | 16.00 |
| Pivot Point | 14.92 | 14.92 | 14.99 | 14.98 | 14.92 |
| Support 1 (S1) | 14.64 | 14.62 | 14.78 | 14.75 | 14.29 |
| Support 2 (S2) | 14.13 | 14.43 | 14.19 | 14.22 | |
| Support 3 (S3) | 13.85 | 14.13 | 14.16 | ||
| Support 4 (S4) | 13.96 |
